Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Tang, S.C.; Leung, J.C.; Chan, L.Y.; Eddy, A.A.; Lai, K.N.
    Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy (2008), Kidney Int., 73, 288-299.
    View publication on PubMed

Application

EC Number Application Comment Organism
3.4.15.1 medicine angiotensin-converting enzyme inhibition confers renoprotection in adriamycin nephropathy by reducing intrarenal angiotensin II and augmenting expression of N-acetylseryl-aspartyl-lysyl-proline that together attenuate signaling of mitogen-activated protein kinase and its downstream proinflammatory and fibrinogenic properties Mus musculus

Inhibitors

EC Number Inhibitors Comment Organism Structure
3.4.15.1 captopril angiotensin-converting enzyme inhibition confers renoprotection in adriamycin nephropathy by reducing intrarenal angiotensin II and augmenting expression of N-acetylseryl-aspartyl-lysyl-proline that together attenuate signaling of mitogen-activated protein kinase and its downstream proinflammatory and fibrinogenic properties Mus musculus

Organism

EC Number Organism UniProt Comment Textmining
3.4.15.1 Mus musculus
-
-
-